Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ
Molecular Nutrition & Food Research · 2026-07 · 70 (13)
DOI: 10.1002/mnfr.70539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 13.07.2026. Verfasst von Zihan Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, P.R. China. Hauptthemen laut MEDLINE: Anthocyanins, NF-kappa B, Glucosides, Inflammatory Bowel Diseases. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Special Fund Project for Basic Research of Zhenjiang, Innovation Special Fund of Danyang, Zhenjiang Science and Technology Plan.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterized by immune dysregulation and an imbalance in the gut microbiota. Cyanidin‐3‐O‐glucoside (C3G), a natural anthocyanin with anti‐inflammatory properties, shows therapeutic potential, though its mechanisms remain incompletely defined. This study evaluated the effects of C3G on intestinal inflammation, microbiota, metabolites, and nuclear factor‐κB (NF‐κB) signaling in a dextran sulfate sodium (DSS)‐induced colitis model in BALB/c mice. In vitro RAW264.7 cells were used to assess pathway involvement. Molecular and histological analyses were performed using qRT‐PCR, Western blotting, and immunostaining, while microbiota and metabolite profiles were analyzed by 16S rDNA sequencing and UHPLC/Q‐TOF‐MS. C3G attenuated colitis severity, improved histological damage, increased interleukin‐10, and reduced IL‐1β, IL‐6, and TNF‐α levels. NF‐κB activation was inhibited, accompanied by enhanced anti‐inflammatory macrophage polarization. C3G also altered gut microbiota composition, reducing pathogenic taxa and enriching beneficial microbes. Metabolomic analysis identified 1‐deoxynojirimycin (1‐DNJ) as associated with C3G treatment. Overall, C3G modulates inflammatory responses, microbiota composition, and NF‐κB signaling in experimental colitis and is associated with changes in 1‐DNJ, warranting further mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, P.R. China.
- Danyang Maternal and Child Health Hospital, Zhenjiang, Jiangsu, P.R. China.
- Department of Gastroenterology, Institute of Digestive Disease, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu, P.R. China.
Förderung
- Special Fund Project for Basic Research of Zhenjiang
- Innovation Special Fund of Danyang
- Zhenjiang Science and Technology Plan
Zitieren
APA
Zhao, Z., Zhou, X., Muro, P., Jiang, H., Kong, H., Wu, S., Zhou, Y., Mao, F., & Yao, D. (2026). Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ. Molecular Nutrition & Food Research, 70(13). https://doi.org/10.1002/mnfr.70539
Vancouver
Zhao Z, Zhou X, Muro P, Jiang H, Kong H, Wu S, et al. Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ. Molecular Nutrition & Food Research. 2026;70(13). doi:10.1002/mnfr.70539
BibTeX
@article{Zhao2026,
author = {Zhao, Zihan and Zhou, Xiangjun and Muro, Peter and Jiang, Hua and Kong, Hao and Wu, Suohua and Zhou, Yong and Mao, Fei and Yao, Dongming},
title = {Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ},
journal = {Molecular Nutrition & Food Research},
year = {2026},
volume = {70},
number = {13},
doi = {10.1002/mnfr.70539}
}
EUVIMED